会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHODS FOR CLONAL DERIVATION OF HUMAN BLASTOCYST-DERIVED STEM CELL LINES
    • 人造血干细胞移植细胞系的克隆方法
    • WO2005059116A1
    • 2005-06-30
    • PCT/EP2004/014016
    • 2004-12-08
    • CELLARTIS ABLINDAHL, AndersKARLSSON, Ulrika
    • LINDAHL, AndersKARLSSON, Ulrika
    • C12N5/02
    • C12N5/0606C12N2501/115C12N2502/13C12N2509/00
    • Human blastocyst-derived stem cells (hBS) or hBS derived cells, such as, e.g., cells of endodermal, mesodermal, and ectodermal origin, are pluripotent cells with widespread potentials within the areas of e.g. therapeutic treatment, human developmental biology, and drug discovery processes. The present invention relates to a method for clonal derivation of human blastocyst-derived stem cells (hBS) or hBS derived cells. According to the present invention hBS cell colonies or hBS derived cell colonies are subjected to non-enzymatic treatment for dissociation of the cell colonies to one or more single cells, which are then separately cultivated in a serum based medium and/or serum based conditioned medium to obtain one or more cell clones capable of forming colonies.
    • 人胚泡来源的干细胞(hBS)或hBS衍生的细胞,例如内胚层,中胚层和外胚层来源的细胞,是具有广泛潜力的多能细胞。 治疗性治疗,人类发育生物学和药物发现过程。 本发明涉及一种用于人源胚泡干细胞(hBS)或hBS衍生细胞克隆衍生的方法。 根据本发明,将hBS细胞集落或hBS衍生的细胞集落进行非酶处理以将细胞集落解离成一个或多个单细胞,然后将其单独培养在基于血清的培养基和/或血清基条件培养基 以获得能够形成菌落的一个或多个细胞克隆。